Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 53 pseudogene (RNU7-53P) is classified as a pseudogene of U7 small nuclear RNA, not an active receptor, enzyme, or therapeutic target[1]. Pseudogenes are DNA sequences similar to normal genes but generally nonfunctional, usually resulting from gene duplication or retrotransposition events. The functional form, U7 small nuclear RNA (U7 snRNA), is an essential component of the U7 small nuclear ribonucleoprotein (snRNP), which is involved in the 3' end processing of replication-dependent histone pre-mRNA in eukaryotic cells[5][3]. The functional U7 snRNA, encoded by other genes such as RNU7-1, is critical for proper histone mRNA maturation, DNA replication, and cell division[2][4]. However, the RNU7-53P pseudogene does not produce functional RNA or protein and does not participate in any known biological, disease, or therapeutic processes[1]. Key points: - RNU7-53P is **not an active gene, receptor, or druggable target**; it is a non-functional pseudogene[1]. - It has **no known molecular, biological, or pathological functions**. - No interacting drugs, mechanisms of action, biomarkers, or safety concerns are associated with this pseudogene. - The functional equivalent, U7 snRNA (from RNU7-1), plays an essential cellular role, but **RNU7-53P does not**. This target is **incorrect for drug or therapeutic consideration** due to its pseudogene classification and lack of function[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 53 pseudogene (RNU7-53P).